Home/Filings/4/0001437749-19-001522
4//SEC Filing

Byrne Thomas E 4

Accession 0001437749-19-001522

CIK 0001053691other

Filed

Jan 29, 7:00 PM ET

Accepted

Jan 30, 9:06 AM ET

Size

5.4 KB

Accession

0001437749-19-001522

Insider Transaction Report

Form 4
Period: 2019-01-02
Byrne Thomas E
General Counsel
Transactions
  • Award

    Stock Option (Right to Buy)

    2019-01-03+2,6672,667 total
    Exercise: $2.10Exp: 2029-01-02Common Stock (2,667 underlying)
Footnotes (1)
  • [F1]The shares underlying the options vest in 36 equal (or as nearly equal as possible) monthly installments on the last calendar day of each month over a three-year period beginning on January 31, 2019.

Issuer

Diffusion Pharmaceuticals Inc.

CIK 0001053691

Entity typeother

Related Parties

1
  • filerCIK 0001663220

Filing Metadata

Form type
4
Filed
Jan 29, 7:00 PM ET
Accepted
Jan 30, 9:06 AM ET
Size
5.4 KB